Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints

Mikucki, M. E., Fisher, D. T., Matsuzaki, J., Skitzki, J. J., Gaulin, N. B., Muhitch, J. B., Ku, A. W., Frelinger, J. G. +4 more·2015·Nature Communications

DOI 10.1038/ncomms8458

Cited by (512)

Items 401–500 of 512

A Spatiotemporal Model of CXCL10 as a Master Regulator of Immune Evasion and Metastasis in Osteosarcoma
Benjamin Baffour Gyau, Tsz-Kwong Chris Man · 2025 · International Journal of Molecular Sciences
CD4 + T cells facilitate the RT-induced abscopal effect by promoting antigen cross-presentation to CD8 + T cells at unirradiated tumor sites
Xi Rao, Kateryna Onyshchenko, Meidan Wang, Ren Luo, Xuanwei Zhang, Liqun Wang, Siegmar Kuhn, Yizhou Yang, Simone Gaedicke, Prof Anca-Ligia Grosu et al. · 2026 · Journal for ImmunoTherapy of Cancer
Creatine uptake promotes dendritic cell activation and enhances antitumor immunity
Elliot Kang, James Elsten-Brown, Yu-Chen Wang, Ashley Lam, Elise Sanchez, Renee Wen, Tiffany L. Wang, Jennifer Chiang, Quentin Scarborough, Yan-Ruide Li et al. · 2026 · iScience
Bridging clinical gaps in personalized cancer neoantigen vaccines
Karam Khaddour, Patrick Alexander Ott · 2026 · Cancer Cell
Modern T cell technologies for immunotherapy of solid tumors
Maria S. Kuznetsova, Hiroshi Shiku, Alexander Viktorovich Karaulov, Sergey Vitalievich Sennikov · 2023 · Medical Immunology (Russia)
Single-cell adhesive profiling in an optofluidic device elucidates CD8+ T lymphocyte phenotypes in inflamed vasculature-like microenvironments
Camila P. Camargo, Yunus Alapan, Abir K. Muhuri, Samuel N. Lucas, Susan Napier Thomas · 2024 · Cell Reports Methods
Computational identification of migrating T cells in spatial transcriptomics data
Lin Zhong, Bo Li, Zhikai Chi, Siyuan Zhang, Qiwei Li, Guanghua Xiao · 2026 · JCI Insight
A novel method to produce synthetic murine CXCL10 for efficient screening of functional variants
Jérémie Decalf, Jeffrey Tom, Elaine Mai, Hilda Hernández-Barry, Cameron L. Noland, Breanna S. Vollmar, Alice Li, Hong Li, Daniel Xie, Lunchao Zhu et al. · 2021 · Bioorganic Chemistry
Soluble bone marrow CXCL-10: a novel biomarker for B-acute lymphoblastic leukemia’s response to induction chemotherapy
Salah Aref, Enas Gouda, Ahmed Al Tantawy, Ahmed Aref, Mohamed Ben Ayed · 2022 · Comparative Clinical Pathology
Mechanisms of Resistance and Strategies to Combat Resistance in PD-(L)1 Blockade
John Moise, Jeevan J. Murthy, Dolma Dabir, Stephen Yu, Farah Kisto, Emily Herron, Sonikpreet Aulakh · 2022 · Immuno
CXCR3 Expression in Regulatory T Cells Drives Interactions With Dendritic Cells in Tumors to Limit CD8 + T Cell Tumor Immunity
Mariela Alejandra Moreno Ayala, Timothy F. Campbell, Chen‐Yu Zhang, Noa E. Dahan, Alissa K. Danford, Varsha Prakash, Lawrence Feng, Theo Sher, Michel J.P. DuPage · 2022 · SSRN Electronic Journal
Proximity-dependent labeling identifies dendritic cells that prime the antitumor CD4+ T cell response
Gabriel D. Victora, Aleksey Chudnovskiy, Sandra Nakandakari-Higa, Tiago B. R. Castro, Ang Cui, Chia‐Hao Lin, Moshe Sade-Feldman, Brooke K. Phillips, Juhee Pae, Luka Mesin et al. · 2022 · Research Square
Intratumoral administration of mRNA-1273 vaccine delays melanoma growth in mice
Dylan T. Boehm, Kaitlyn M. Landreth, Emel Sen-Kilic, Katherine S. Lee, Bishal Misra, Sharan Kumar Reddy Bobbala, Fredrick Heath Damron, Tracy W. B. Liu · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
LSD1 inhibition corrects dysregulated MHC-I and dendritic cells activation through IFNγ-CXCL9-CXCR3 axis to promote antitumor immunity in HNSCC
Amit Kumar Chakraborty, Lina Kroehling, Rajnikant Dilip Raut, Chumki Choudhury, Maria A. Kukuruzinska, Jorge Silvio Gutkind, Xaralabos Varelas, Bikash Sahay, Stefano Monti, Manish V. Bais · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
Peripheral blood gene expression signatures of systemic immunity predict tumor microenvironment biology and therapeutic response in breast cancer
J. Balko, Xiao-Peng Sun, Ann Hanna, Andres A. Ocampo, Brandie C. Taylor, Jacey Marshall, Julia A. Steele, M. Axelrod, Elizabeth C. Wescott, S. Opalenik et al. · 2025 · Research Square
Chimeric antigen receptor-modified cells for the treatment of solid tumors: First steps in a thousand-mile march
Hind Rafei, Rafet Başar, Katayoun Rezvani, May Daher · 2023 · Elsevier eBooks
Asiatic acid promotes CD8+ T cell-mediated antitumor immunity by targeting HDAC8/CXCL10 axis in hepatocellular carcinoma
Yu‐Chuan Chen, Xue-lian Gao, Ge Zeng, Kai-kai Zhang, Yuan Chang, Chang-Hao Cheng, Jia-Yuan Wan, He-qi Zhou, Zhixian Lan, Dekai Zheng et al. · 2026 · Acta Pharmacologica Sinica
Persistent T cell phenotypic alterations and early innate immune dysregulation as potential biomarkers of Long COVID
Marina Perez Mazzali, Francisco Pérez‐Cózar, Paloma Cal‐Sabater, Paulina Rybakowska, Pablo Telleria, Javier Gamazo, Marina G. De Vicuña, Elisa Arribas‐Rodríguez, Aida Fiz‐López, Carolina G. de Castro et al. · 2026 · Journal of Infection
The CXCL9/SPP1 polarity axis in tumor-associated macrophages: immunoregulatory and prognostic significance in non-small cell lung cancer
Houqiang Li, Miaoyan Liu, Shenghan Xu, Yike Zhou, Youlang Zhou, Jiahai Shi, Lou Zhong · 2026 · Frontiers in Immunology
Determinants of Chimeric Antigen Receptor (CAR) T Cell Success: In Vitro and In Vivo Preclinical Assessment
Michael K. Sheng, William J. Murphy · 2026 · Cancers
Spatial cellular order underlies locally-confined mechanisms of immune resistance in oropharyngeal cancer
Cem M. Sievers, Yvette L. Robbins, Marco Craveiro, Jay Friedman, Angel Huynh, Xinping Yang, Michael C. Kelly, James W. Hodge, Dilara Akbulut, Martha Quezado et al. · 2026 · Nature Communications
The CD49b (ITGA2) collagen receptor excludes CD8+ T cell infiltration in pancreatic ductal adenocarcinoma
Ibrahim Ragab Eissa, Sonia Cohen, Genevieve Marie Boland, Tatyana Y. Sharova, Kenneth K. Tanabe · 2026 · iScience
Beyond density: mapping the functional landscapes of macrophage-T lymphocyte niches in the tumor microenvironment
Serena Zilio, Adrien Rouault, Malvina Seradj, Ilaria Marigo, Armelle Prévost‐Blondel, Elisa Peranzoni, Nadège Bercovici · 2026 · Frontiers in Immunology
The CCL2/CCR2 axis in irradiated tumors: orchestrating immune recruitment and microenvironment remodeling
Baoxu Li, Dianrong Li, Qi Liu, Lin Ma · 2026 · Clinical Cancer Bulletin
Exploiting the CXCR3/CXCL10 axis overrides tumor immune suppression by enhancing immune trafficking and effector cell priming in HNSCC
Charlotte A. Shinn, Robert Saddawi‐Konefka, Catherina L. Salanga, Shiruyeh Schokrpur, Jorge Silvio Gutkind, Tracy M. Handel · 2026 · Proceedings of the National Academy of Sciences
Basic Rules of T Cell Migration
Jens Volker Stein, Federica Moalli, Markus Ackerknecht · 2016 · Resistance to targeted anti-cancer therapeutics
Chimeric antigen receptor T-cells for glioblastoma: The journey ahead
Sujith K. Joseph, Meenakshi G. Hegde, NabilM Ahmed · 2019 · Glioma
Blockade of β-adrenergic receptor signaling improves cancer vaccine efficacy through its effect on naive CD8 + T-cell priming
Clara Daher, Lene Vimeux, Ralitsa Stoeva, Elisa Peranzoni, Georges Bismuth, Emmanuel Donnadieu, Nadège Bercovici, Alain Trautmann, Vincent Feuillet · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
CD40 and CD80/86 signaling in cDC1s mediate effective neoantigen vaccination and generation of antigen-specific CX3CR1 + CD8 + T cells in mice
Takayoshi Yamauchi, Toshifumi Hoki, Takaaki Oba, Kristopher Attwood, Xuefang Cao, Fumito Ito · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
Acquired resistance to PD-L1 inhibition is associated with an enhanced type I IFN-stimulated secretory program in tumor cells
Yuhao Shi, Melissa Dolan, Michalis Mastri, Amber McKenery, James W. Hill, Adam P. Dommer, Sébastien Benzekry, Mark Long, Scott I. Abrams, Igor J. Puzanov et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
Neoadjuvant Vidutolimod and Nivolumab in High-Risk Resectable Melanoma
Diwakar Davar, Robert M. Morrison, Amiran Dzutsev, Arivarasan Karunamurthy, Joe-Marc Chauvin, Florent Amatore, Julie E. Stein, Rodrigo Xavier das Neves, Richard Rosario Rodrigues, John A. McCulloch et al. · 2022 · Research Square
Consequences of the perivascular niche remodeling for tumoricidal T-cell trafficking into metastasis of ovarian cancer
Danuta Kozbor, Marta Winkler, Nemi Malhotra, Anna Mistarz, Sophie Wang, Alan David Hutson, Andrea A. Gambotto, Scott I. Abrams, Prashant Kumar Singh, Song Liu et al. · 2024 · Research Square
PD-L1 ligation on NK cells induces a metabolic shift from glycolysis to fatty acid oxidation, enhancing tumor infiltration and control
Katja Srpan, Kyle B. Lupo, Rosa Sottile, Gianluca Scarno, Clara Lawry, Gabryelle Kolk, Brian C. Shaffer, Snehal G. Patel, Ahmed Al‐Niaimi, Colleen M. Lau et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
NLRC5 expression in tumor cells is critical to activate adaptive and innate antitumor immune responses
Akhil Shukla, A Quenum, Jean‐François Lucier, Anny Armas Cayarga, Dominique Lévesque, François‐Michel Boisvert, Thomas A. Kufer, Sheela Ramanathan, Subburaj Ilangumaran · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
Improving adenovirus-based immunotherapies for treatment of solid tumors
Mikko Siurala · 2017 · Työväentutkimus Vuosikirja
Investigating the Role of Lipopolysaccharide and Polyinosinic:Polycytidylic Acid in Boosting CD4 T cell Responses
Paurvi Shinde · 2017 · OpenCommons at University of Connecticut (University of Connecticut)
Remediação das vias p53/Arf e interferon-beta como uma estratégia de imunoterapia do câncer: uma abordagem de transferência gênica
Ruan F.V. Medrano · 2018
Beyond PD-1/PD-L1 Axis Blockade: New Combination Strategies in Metastatic Melanoma Treatment
Emilio Francesco Giunta, Giuseppe Argenziano, Gabriella Brancaccio, Erika Martinelli, Fortunato Ciardiello, Teresa Troiani · 2018 · Current Cancer Therapy Reviews
Induced pluripotent stem cell-derived, genetically engineered myeloid cells as unlimited cell source for dendritic cell-related cancer immunotherapy
Rong Zhang, Tianyi Liu, Nobuhiro Tsuchiya, Hiroaki Mashima, Tsuyoshi Kobayashi, Tetsuya Nakatsura, Hideki Ohdan, Itaru Endo, Satoru Senju, Yasushi Uemura · 2021 · Journal of Immunology and Regenerative Medicine
Expansion of tumor-infiltrating lymphocytes with substantial stem cell properties from vulvar cancer
Tingting Yao, Yarong Liu · 2021
Faculty Opinions recommendation of Hedgehog signaling promotes tumor-associated macrophage polarization to suppress intratumoral CD8+ T cell recruitment.
Paul R. Walker, Stoyan Tankov · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
Data from Site-Dependent Immune Escape Due to Impaired Dendritic Cell Cross-Priming
Mark S. Diamond, Jeffrey Lin, Robert H. Vonderheide · 2023
Systematic pan-cancer analysis reveals XCR1 as a Prognostic and Immunological Biomarker
Likun Cui, Jie Chen, Chunzhen Li, Yizhi Yu, Sheng Xu · 2023 · Research Square
Avaliação de quimiocinas circulantes em pacientes com câncer de mama, o ardiloso luminal b e as misteriosas quimiocinas
Rogério Araújo · 2023
Expansion of Tumor-Infiltrating Lymphocytes (TILs) with Substantial Stemness Properties from Vulvar Cancer
Tingting Yao, Zixiao Shi, Jingwei Sun, Yuhan Wang, Haijian Zhou, Yanru Chen, Di Zhou, Zhongqiu Lin, Yarong Liu · 2023 · Journal of Vaccines Immunology and Immunopathology
Пухлиноінфільтруючі лімфоцити: нові виклики імунотерапії солідних пухлин
O.Yu. Nikolaieva · 2023 · Practical oncology
Differentiation and Expansion of Tumor-Infiltrating T Cell Clonotypes Occurs in the Spleen Following Immune Checkpoint Blockade
Duncan M. Morgan, Brendan L. Horton, Maria Zagorulya, John Christopher Love, Stefani Spranger · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
Characterization of the Cytotoxic T lymphocytes Acute Response Following Continuous Moderate Intensity and High Intensity Interval Exercise in Metastatic Cancer Patients Undergoing Chemotherapy
Hugo Parent-Roberge, Adeline Fontvieille, Laurence Poirier, Lee‐Hwa Tai, Michel Pavic, Tamàs Fülöp, Éléonor Riesco · 2023
A spatiotemporal comparative analysis on tumor immune microenvironment characteristics between neoadjuvant chemotherapy and preoperative immunotherapy for ESCC
Yi Ba, Zhengyang Zhou, Hongdian Zhang, Jiayu Yang, Tongtong Wang, Wen Pan, Qiumo Zhang, Huiya Wang, Peng Tang, Haiyang Zhang · 2023 · Research Square
Adoptive T-Cell Therapy for the Treatment of Lung Cancer
Jayaraman Rajangam, Vasanth Raj Palanimuthu, Dinesh Kumar Upadhyay, Lucy Mohapatra, Navanita Sivaramakumar, Narahari Narayan Palei, Priyal Soni · 2024 · Springer eBooks
Cd8+T Cells Infiltrating into Tumors Were Controlled by Immune Status of Draining Lymph Nodes and Correlated with Non-Small Cell Lung Cancer (Nsclc) Patients’ Prognosis Treated with Chemoimmunotherapy
Zhexin Bai, Xu Cheng, Tianyu Ma, Gege Li, Xiaojue Wang, Ling Yi, Zhexin Bai, Zhidong Liu · 2024 · SSRN Electronic Journal
CXCR3-Flavonoid Interaction: A Novel Therapeutic Approach in Cancer Immunotherapy
Hatice Güngör, Aliye Demet Demirağ · 2024 · Kocaeli Üniversitesi Sağlık Bilimleri Dergisi
Peripheral T lymphocyte immune characteristics dictate response to transarterial chemoembolization in unresectable hepatocellular carcinoma
Lei Peng, Qi Liang, Pengfei Rong, Shengwang Zhang, Huan Chen, Huaping Liu, Xiaoqian Ma, Wei Wang · 2025 · Therapeutic Advances in Gastroenterology
Engineered chemokines, resistant to cancer-mediated post-transcriptional modifications, as drugs to improve cancer immunotherapy
Ofer Mandelboim, Angel Porgador · 2025 · Proceedings of the National Academy of Sciences
Sex parity in stimulation of murine lymphocyte trafficking in response to fever-range systemic thermal therapy
Michelle M. Appenheimer, Arwen A. Tisdale, Daniel T. Fisher, Han Yu, Elizabeth A. Repasky, Sharon S. Evans · 2025 · International Journal of Hyperthermia
Characterize febrile temperature dependency of anti-infection pathways in Salmonella-infected mouse macrophages
Zhaojun Xu, Yefei Zhan, Qifa Song · 2025 · Microbial Pathogenesis
Aurka orchestrates colorectal cancer progression through dual regulation of tumor proliferation and immune microenvironment
Yidong Xu, Wei Wang, Jiazi Yu, Jianpei Zhao, Xiaoyu Dai, Zhongchen Liu · 2025 · Research Square
Combination of low-intensity pulsed ultrasound irradiating immune organs with immune checkpoint blockade augments systemic anti-tumor immunity on low tumor burden 4T-1 breast cancer
Jixi Li, Liling Wen, Yujun Guo, Dan Yao, Bihang Sun, Hai Mou, Nianzhi Chen, Kun Li Zhou, Yan Wang, Wenzhi Chen · 2025 · Cancer Immunology Immunotherapy
The CXCL10/CXCR3 axis is essential for sustaining immunological dormancy in breast cancer
Alev Yilmaz, Lisa Haerri, Mateo Estrella Granda, Oriana Coquoz, Qiang Lan, Curzio Rüegg · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
The 41BB-agonist potentiates the therapeutic efficacy of a combined irreversible electroporation ablation treatment of lung cancer by promoting unexpected CD8+CD103+ cDC1 and tissue-resident memory T cell responses
Fang Chen, Zhaojia Wu, Scot C. Leary, Yiling Bai, Michelle Yu, Nicolas Baniak, Shahid Ahmed, Gary Groot, Mike Moser, Wenjun Zhang et al. · 2025 · Frontiers in Immunology
Immunotherapy of Lung Tumors
Helmut Popper · 2025 · Springer eBooks
CD74 regulates antitumor immunity in melanoma by reprogramming dendritic cell immunogenicity and migration
Eleftheria Maranou, Ga‐Young Park, Pauline Weinzettl, Jonna Alanko, Otto I. Pulkkinen, Sarah E. Coupland, Marko Salmi, Carlos R. Figueiredo · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
Additional file 7 of RORγt agonist enhances anti-PD-1 therapy by promoting monocyte-derived dendritic cells through CXCL10 in cancers
Xia, Li, Tian, Enming, Yu, Mingcheng, Liu, Chenglong, Shen, Lian, Huang, Yafei, Zhongen Wu, Tian, Jinlong, Yu, Ker, Wang, Yonghui et al. · 2022 · Figshare
Additional file 6 of RORγt agonist enhances anti-PD-1 therapy by promoting monocyte-derived dendritic cells through CXCL10 in cancers
Xia, Li, Tian, Enming, Yu, Mingcheng, Liu, Chenglong, Shen, Lian, Huang, Yafei, Zhongen Wu, Tian, Jinlong, Yu, Ker, Wang, Yonghui et al. · 2022 · Figshare
Additional file 1 of Delivery of CXCL9/10/11 plasmid DNAs promotes the tumor-infiltration of T cells and synergizes with PD1 antibody for treating lung cancer
Ma, Yuxia, Liu, Yi, Zhi, Ying, Wang, Haibin, Mei Yang, Niu, Jieting, Li Zhao, Wang, Pengsheng · 2022 · Figshare
Additional file 3 of RORγt agonist enhances anti-PD-1 therapy by promoting monocyte-derived dendritic cells through CXCL10 in cancers
Xia, Li, Tian, Enming, Yu, Mingcheng, Liu, Chenglong, Shen, Lian, Huang, Yafei, Zhongen Wu, Tian, Jinlong, Yu, Ker, Wang, Yonghui et al. · 2022 · Figshare
Additional file 2 of RORγt agonist enhances anti-PD-1 therapy by promoting monocyte-derived dendritic cells through CXCL10 in cancers
Xia, Li, Tian, Enming, Yu, Mingcheng, Liu, Chenglong, Shen, Lian, Huang, Yafei, Zhongen Wu, Tian, Jinlong, Yu, Ker, Wang, Yonghui et al. · 2022 · Figshare
Additional file 4 of RORγt agonist enhances anti-PD-1 therapy by promoting monocyte-derived dendritic cells through CXCL10 in cancers
Xia, Li, Tian, Enming, Yu, Mingcheng, Liu, Chenglong, Shen, Lian, Huang, Yafei, Zhongen Wu, Tian, Jinlong, Yu, Ker, Wang, Yonghui et al. · 2022 · Figshare
Additional file 1 of RORγt agonist enhances anti-PD-1 therapy by promoting monocyte-derived dendritic cells through CXCL10 in cancers
Xia, Li, Tian, Enming, Yu, Mingcheng, Liu, Chenglong, Shen, Lian, Huang, Yafei, Zhongen Wu, Tian, Jinlong, Yu, Ker, Wang, Yonghui et al. · 2022 · Figshare
Additional file 5 of RORγt agonist enhances anti-PD-1 therapy by promoting monocyte-derived dendritic cells through CXCL10 in cancers
Xia, Li, Tian, Enming, Yu, Mingcheng, Liu, Chenglong, Shen, Lian, Huang, Yafei, Zhongen Wu, Tian, Jinlong, Yu, Ker, Wang, Yonghui et al. · 2022 · Figshare
Additional file 1 of Cyclin G2 in macrophages triggers CTL-mediated antitumor immunity and antiangiogenesis via interferon-gamma
Liu, Lu, Jinlan Gao, Xing, Xuesha, Meixi Jiang, Liu, Qi, Wang, Shusen, Yang Luo · 2024 · Figshare
TMEM33 deletion potentiates anti-tumor CD8 + T cell immunity
Matthew P. Jackson, T. Zhao, Gusztav Milotay, Isabela Pedroza‐Pacheco, Yanshu Cai, Claire Willis, Su Myat Phyu, Bruno Beernaert, J. Kwon, Hala Estéphan et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
Semaphorins: from CD8⁺ T cells to cancer immunotherapy
Zhiying Liu, Yi Wu, Peiqi Xu, Huaxi Xu, Kai Yin, Shengjun Wang · 2026 · Biomarker Research
Impact of GM-CSF and Two-Site Vaccination on Clinical Outcomes after Multipeptide Vaccination for Melanoma: Long-term Analysis of a Randomized Phase II Trial
Emily K. Ninmer, Hong Zhu, Amrita Sarkar, Kimberly A. Chianese‐Bullock, Merrick I. Ross, Naomi Balzer Haas, Margaret von Mehren, Marc E. Boisvert, John M. Kirkwood, Craig Lee Slingluff · 2026 · Clinical Cancer Research
Autophagy meets tissue-resident memory: Emerging crosstalk and therapeutic opportunities in cutaneous melanoma
Bogdan Toma, Mariana Pavel Tanasa, Mihai Danciu · 2026 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Impact of Targeting the Autophagy Related Gene Beclin 1 on the Immune Landscape of Melanoma
Tsolère Arakelian · 2018
Nanophysical and pharmacological approaches to modulate tumor stiffness, extracellular matrix organization and immune response of solid tumors
Alba Nicolás‐Boluda · 2019
Xeroderma Pigmentosum syndrome : A new model to study the role of fibroblasts in the modulation of the innate immune response against cutaneous cancer cells
Maria Gonçalves-Maia · 2019
Influence des interactions neuro-immunes sur la croissance tumorale et l'immunité anti-tumorale associée
Clara Daher · 2022
Decoding the cellular interactions regulating CAR T cell antitumor activity in vivo using two-photon intravital imaging
Marine Cazaux · 2020 · theses.fr (ABES)
Characterization of the Tumor Microenvironment in Chronic Lymphocytic Leukemia by Mass Cytometry : Implications for Immunotherapy
Marina Wierz · 2020
Characterization of tumor-infiltrating myeloid cells in a mouse model of melanoma : roles of IL-4Rα signaling and tumor cell immunogenicity
Elodie Baudoin · 2021 · theses.fr (ABES)
Etude de l’influence du TGF-β sur les sous-populations de fibroblastes associés au cancer et leur implication pronostique dans les cancers du pancréas
Angélique Vienot · 2021 · theses.fr (ABES)
Harnessing gene expression profiling to infer the activation states of dendritic cell types, their dynamical relationships and their molecular regulation
Ammar Sabir Cheema · 2023
Defining the differential contributions of CD4+ and CD8+ T cells to CAR T cell therapy against B cell malignancies
Morgane Boulch · 2022 · theses.fr (ABES)
Tumor Endothelial ITGA5 Expression Induces T cell Dysfunction in Cervical Cancer
Lu Shen, Xiaoqiu Dai, Yue Liu, Yayun Zhang, Xiaoxue Xi, Xiao Wu, Chen Wang, Peng Lin · 2026 · Research Square
Chemoresistance and Immune Suppression in Gastric Cancer Are Driven by PPDPF Overexpression
Chenqiang Pan, Rongxing Hu, Bing Wu, Lei Tan, Zhiqiang Yan · 2026 · Chemical Biology & Drug Design
Beyond priming: a sequential, feedback-guided adjuvant framework for therapeutic cancer peptide vaccines in immunologically cold tumors
Corey K. Goldman · 2026 · Frontiers in Immunology
Genetically Unmodified Cells for Drug Delivery and Therapy
Bo-Wen Zhang, Ying Chen, Chao-Jie Zhu, Qiu-Jun Qiu, Zhen Gu, Hong-Jun Li · 2026 · ACS Nano Medicine
Oncolytic virotherapy with chimeric rVSV-NDV causes tumor-specific immunity in a DC-activation-dependent manner
Lorenz Hanesch, Nina Hartmann, Sonja Glauß, Tianle Feng, Jennifer Altomonte · 2026 · Molecular Therapy Oncology
Navigating the landscape of CD8+ T cell tumor infiltration: Barriers, mechanisms, and therapeutic opportunities
Zhengkui Zhang, Yuanzhuo Gu, Shilei Qiao, Linpeng Sang, Long Zhang, Fangfang Zhou · 2026 · Cell Press Blue
Emerging trends and future outlook towards magnetic nanoparticles as frontiers in cancer immunotherapy
Akshay Kumar, Vishal Singh, Kamal Kumar, Nitin Kumar Singhal, Shubham Kumar · 2026 · Nanoscale
RNA exonuclease REXO4 resolves m6A-marked R-loops and suppresses anti-tumor immunity
Jieyou Zhang, Kaiwen Bao, Yayan Hou, Nixian Zhao, Qi Chen, Zhenzhen Yang, Rongfang Nie, Chunyong Zhang, Huasheng Wang, Heng Zhang et al. · 2026 · Molecular Cell
Resetting the immune setpoint of cold tumors through a ferroptosis–cGAS–STING amplification circuit
Yi Wang, X G Li, Yuan Liang, Yawen Li, Yixin Zhao, Pengna Guo, Yuguang Zhao · 2026 · Journal of Translational Medicine
Inorganic nanomaterials activate the cGAS-STING pathway for tumor treatment
Youdong Chen, Qian Li, Jinhua Zhou, Liang Cheng · 2026 · Pharmacology & Therapeutics
Reprogramming CAR-T Cell Therapy for Solid Tumors: Combination Strategies to Overcome Resistance
Wei Cheng, Mei‐Lan Liu, Yu-Hua Diao, Bingkun Chen, Yi-Peng Wen, Chi Zhang, Man-Ting Liu, Zi-Qi Shao, Jian-Yu Cai, Bihui Cao · 2026 · Cancer Biome and Targeted Therapy
The acute response of cytotoxic T cells following work-matched continuous moderate-intensity and high-intensity interval exercise in metastatic cancer patients undergoing chemotherapy: a pilot study
Hugo Parent-Roberge, Adeline Fontvieille, Laurence Poirier, Lee‐Hwa Tai, Michel Pavic, Tamas Fulop, Éléonor Riesco · 2026 · Applied Physiology, Nutrition, and Metabolism
Characterization of tumour-infiltrating lymphocytes in a tumour rejection cynomolgus macaque model.
大樹里岡, 宏仁石垣, 景史藤堂, Koshi Terada, 縣保年, 靖伊藤, 小笠原一誠, Takako Hirata, Hiroki Satooka, Hirohito Ishigaki et al. · 2020 · Institutional Repositories DataBase (IRDB)
SPRED2 Negatively Regulates CD8 + T Cell‐Mediated Antitumor Immunity in Breast Cancer
Miao Tian, Teizo Yoshimura, Kun Zhao, Chunning Li, Tong Gao, Ziyi Wang, Masayoshi Fujisawa, Toshiaki Ohara, Akihiro Matsukawa · 2026 · Advanced Science
Peripheral CXCR3 blockade mitigates T cell infiltration and neurodegeneration in a mouse model of tauopathy
Joshua T. Emmerson, Hao Hu, Vivek Savani, Peter Bor‐Chian Lin, Mina Rohde, Prabal Sharma, Wade K. Self, Yongyi Li, Jonathan Nulman, Megan E. Bosch et al. · 2026 · Neuron